IN8bio Inc (INAB)
1.03
+0.04
(+3.99%)
USD |
NASDAQ |
May 01, 16:00
1.01
-0.02
(-1.94%)
After-Hours: 19:11
IN8bio Enterprise Value: 21.59M for April 30, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 30, 2024 | 21.59M |
| April 29, 2024 | 21.58M |
| April 26, 2024 | 23.74M |
| April 25, 2024 | 23.74M |
| April 24, 2024 | 24.60M |
| April 23, 2024 | 23.74M |
| April 22, 2024 | 22.00M |
| April 19, 2024 | 23.30M |
| April 18, 2024 | 24.17M |
| April 17, 2024 | 22.01M |
| April 16, 2024 | 21.15M |
| April 15, 2024 | 22.87M |
| April 12, 2024 | 26.77M |
| April 11, 2024 | 28.50M |
| April 10, 2024 | 26.33M |
| April 09, 2024 | 25.90M |
| April 08, 2024 | 25.90M |
| April 05, 2024 | 26.33M |
| April 04, 2024 | 27.20M |
| April 03, 2024 | 23.74M |
| April 02, 2024 | 26.33M |
| April 01, 2024 | 28.50M |
| March 28, 2024 | 29.80M |
| March 27, 2024 | 31.10M |
| March 26, 2024 | 32.83M |
| Date | Value |
|---|---|
| March 25, 2024 | 30.66M |
| March 22, 2024 | 32.39M |
| March 21, 2024 | 32.83M |
| March 20, 2024 | 34.13M |
| March 19, 2024 | 30.66M |
| March 18, 2024 | 31.96M |
| March 15, 2024 | 28.07M |
| March 14, 2024 | 28.93M |
| March 13, 2024 | 32.83M |
| March 12, 2024 | 33.69M |
| March 11, 2024 | 33.69M |
| March 08, 2024 | 34.99M |
| March 07, 2024 | 31.53M |
| March 06, 2024 | 28.50M |
| March 05, 2024 | 32.39M |
| March 04, 2024 | 31.10M |
| March 01, 2024 | 25.90M |
| February 29, 2024 | 26.77M |
| February 28, 2024 | 28.50M |
| February 27, 2024 | 26.77M |
| February 26, 2024 | 21.34M |
| February 23, 2024 | 19.97M |
| February 22, 2024 | 22.44M |
| February 21, 2024 | 23.30M |
| February 20, 2024 | 23.95M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
5.947M
Minimum
Jun 16 2022
210.62M
Maximum
Jul 30 2021
42.23M
Average
28.27M
Median
Enterprise Value Benchmarks
| Jaguar Health Inc | 90.97M |
| Aptevo Therapeutics Inc | -16.52M |
| NovaBay Pharmaceuticals Inc | 2.389M |
| Palatin Technologies Inc | 20.53M |
| iBio Inc | 15.83M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -7.598M |
| Total Expenses (Quarterly) | 7.928M |
| EPS Diluted (Quarterly) | -0.21 |
| Earnings Yield | -98.06% |